No CrossRef data available.
Published online by Cambridge University Press: 29 March 2005
This section is meant to be a mutual effort. If you find an article you think should be abstracted in this section, do not be bashful—submit it for consideration to feature editor Kenneth V. Iserson care of CQ. If you do not like the editorial comments, this will give you an opportunity to respond in the letters section. Your input is desired and anticipated.
Woolhead G, Calnan M, Dieppe P, Tadd W. Dignity in older age: What do older people in the United Kingdom think? Age & Ageing 2004;33(2):165–70.
Although bioethicists often use the term “dignity,” especially when discussing quality of life and end-of-life issues, there is little empirical research to show how older people view dignity. This study used qualitative methods to explore the concept of dignity from the older person's perspective. Fifteen focus groups and two individual interviews were conducted in 12 different settings, with a total of 72 participants. Participants were purposively sampled to ensure a mix of socioeconomic status, ethnicity, gender, age (65+), and fitness level. The authors audiotaped and transcribed focus group sessions, using the method of constant comparison to analyze the data. They found strong evidence to suggest that dignity was a serious concern of older people. The elderly generally viewed dignity in several ways: (i) dignity of identity (self-respect/esteem, integrity, trust); (ii) human rights (equality, choice); and (iii) autonomy (independence, control). They found that the elderly suffered a loss of self-esteem when being patronized, excluded from decisionmaking, and being treated as an “object.” Many of the respondents believed that a lack of integrity in society led to their inability to trust others and sensed that they were particularly vulnerable. Equality was also an important issue, and many felt that British government policies did not support their rights. This study suggests that policy makers and professionals who wish to tailor policies and practices to the needs of older people should focus on communication, privacy, personal identity, and feelings of vulnerability.
Mosesso VN Jr, Brown LH, Greene HL, Schmidt TA, Aufderheide TP, Sayre MR, et al. Conducting research using the emergency exception from informed consent: The Public Access Defibrillation (PAD) Trial experience. Resuscitation 2004;61(1):29–36.
As an increasing number of investigators apply to Institutional Review Boards (IRBs) for exceptions from informed consent for emergency research, these authors of a multicenter trial assessed the approval process for such a waiver at multiple sites. The authors are involved in the Public Access Defibrillation (PAD) Trial, a prospective, multicenter, randomized clinical trial comparing two prehospital resuscitation strategies, which they conducted under the regulations for exception from informed consent (21CFR50.24) in 24 North American communities. These regulations place additional requirements for human subject protection on investigators and IRBs, including conducting community consultation (CC) and public disclosure (PD). To describe the IRB approval process at U.S. and Canadian study sites and the number and types of CC and PD activities conducted, they assessed the required IRB applications, CC and PD plans, and a structured report on IRB processes for the 24 study sites (with 101 IRBs involved). The primary IRBs for all 24 trial sites and a total of 101 IRBs approved the study. The median interval from submission to approval was 108 days (IQR 43–196), and the mean number of revisions was two (range 0–7). Investigators conducted nearly 12,000 activities to achieve CC and PD; activities varied widely from site to site in both type and quantity. The authors conclude that the length of time to obtain IRB approval and the extent of community consultation and public disclosure to meet the current regulations for conducting emergency research with exception from informed consent vary greatly among trial sites. This suggests that more specific guidance may be useful and that determination of effective strategies for community consultation and public disclosure is needed.
Powner DJ, Hernandez M, Rives TE. Variability among hospital policies for determining brain death in adults. Critical Care Medicine 2004;32(6):1284–8.
Death by brain criteria (“brain death”) enters into many bioethics scenarios, especially the decision to donate organs. In the absence of federal requirements or state statutes, individual hospitals' medical staff and administrative policies specify the criteria to certify brain death. With the supposition that variability among such policies may allow inconsistency in these determinations, these authors used a survey to partially quantify the diversity among hospital standards used to certify brain death. They conducted a survey of 600 hospitals randomly selected from the American Hospital Association registry representing 200 hospitals each of <300 beds, 300–500 beds, and >500 beds. They compared the 106 policies submitted by these institutions against variables recommended by the American Academy of Neurology. They found significant variability in policy criteria compared with the American Academy of Neurology and other authoritative standards. Differences were greatest in specifying conditions to be excluded before testing and in specific testing methods during a detailed physical examination. The authors believe that the few differences noted between larger versus smaller hospitals most likely reflect larger institutions' greater resource availability. The authors conclude that the variability among hospital policies for certification of death by brain criteria suggests that standardization and enforcement of policies that ensure the highest possible accuracy should be considered.
Vollmann J, Burchardi N, Weidtmann A. [Health care ethics committees in German university clinics. A survey of all medical directors and directors of nursing]. [German] Deutsche Medizinische Wochenschrift 2004;129(22):1237–42.
Healthcare Ethics Committees (HECs) are relatively new actors within healthcare institutions, and scarce in Europe. While U.S. acute care hospitals must provide some structure to handle ethical conflicts in patient care, only a minority of German hospitals, often members of the Protestant or Catholic Hospital Associations, have HECs. Because it was unclear whether German university hospitals had methods for ethical case resolution and what their most common ethical dilemmas were, in November 2002, these authors sent 13-item questionnaires to all medical directors and directors of nursing at the 36 German university hospitals. Eighty-two percent of respondents identified the most pressing ethical issues in their practices as being limitation of treatment, informed consent, and the conflict between beneficence and autonomy. Nursing directors estimated a greater need for additional staff support to resolve ethical issues than did medical directors. Both identified improvement in interdisciplinary teamwork, further education in ethics, and ethical guidelines as ways to improve ethical professional performance. However, the nursing directors mentioned the lack of time and the low priority of ethics as problems in implementing these measures more often than did medical directors. Five German university hospitals plan to establish an HEC and two hospitals want to employ a clinical ethicist. The authors conclude that German university hospitals could benefit from having HECs, but that the majority of them do not have either the knowledge about or interest in beginning such groups.
Shah S, Whittle A, Wilfond B, Gensler G, Wendler D. How do institutional review boards apply the federal risk and benefit standards for pediatric research? JAMA 2004;291(4):476–82.
Federal regulations allow children in the United States to be enrolled in clinical research only when the institutional review board (IRB) determines that the risks are minimal or nearly minimal, or that the research may offer direct benefit to the child. Consistent with the paucity of information on IRB function, no data exist on how IRBs apply the risk and benefit categories to pediatric research. These authors from NIH used a telephone survey to determine how IRB chairpersons apply these risk–benefit categories to pediatric research. Between May and August 2002, they contacted 188 randomly selected IRB chairpersons in the Unites States. Their survey consisted of 21 questions assessing the application of federal risk standards to research protocols, whether certain interventions offer a prospect of direct benefit to participating children, and the extent to which IRBs use the federal definition of minimal risk when categorizing the risks of research procedures in children. They found that a single blood draw was the only procedure categorized as minimal risk by a majority (152 or 81%) of the 188 IRB chairs surveyed. An electromyogram was categorized as minimal or nearly minimal risk by 100 (53%) and as more than a minor increase over minimal risk by 77 (41%). Allergy skin testing was categorized as minimal risk by 43 IRB chairpersons (23%), nearly minimal risk by 81 (43%), and more than a minor increase over minimal risk by 51 (27%). Regarding benefits, 113 chairpersons (60%) considered added psychological counseling to be a direct benefit, and paying participants was considered a direct benefit by 10% (n = 19). The authors conclude that IRB chairpersons inconsistently apply the federal risk and benefit categories for pediatric research in ways that are sometimes contradicted by the available data on risks and the regulations themselves. To protect children from excessive risks while allowing appropriate research, IRB chairpersons need guidance on applying the federal risk and benefit categories and also need data on the risks children face in daily life and during routine physical or psychological tests.